echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Aripiprazole oral solution is planned to be included in the priority review

    Aripiprazole oral solution is planned to be included in the priority review

    • Last Update: 2021-06-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 15th, the Center for Drug Evaluation (CDE) of the National Food and Drug Administration of China announced that the aripiprazole oral solution of Sichuan Otsuka Pharmaceutical Co.
    , Ltd.
    , a subsidiary of Otsuka Pharmaceutical, is suitable for children’s use.
    The new varieties, dosage forms and specifications of drugs have been included in the priority review by CDE.
    The proposed indications are: irritable symptoms of autism in children and adolescents aged 6-17 years; Tourette syndrome in children and adolescents aged 6-17 years
    .

    Screenshot source: CDE official website

    The aripiprazole oral solution of Sichuan Otsuka Pharmaceutical Co.
    , Ltd.
    is planned to be included in the priority review.
    The proposed indications include autism irritable symptoms and Tourette syndrome
    .


    According to the Chinese drug clinical trial registration and information disclosure platform, the product has previously completed a multi-center, randomized double-blind, variable-dose, placebo-controlled, phase 3 treatment for children and adolescents with autism in China.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.